Drug Development Life Science Pharmaceuticals 
Healthcare IT Today
JANUARY 3, 2025
Check out our community’s Pharma predictions: Dave Latshaw, CEO at BioPhy The competitive dynamics of the pharmaceutical industry will undergo substantial reorganization in 2025. The role of AI-native pharmaceutical companies will expand significantly in 2025, building on the momentum of billions in investment from previous years.
Healthcare IT Today
JANUARY 23, 2024
Accenture announced it has made a strategic investment, through Accenture Ventures , in QuantHealth , an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and cost-effectively develop treatments for patients. Petra Jantzer, Ph.D.,
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Healthcare IT Today
APRIL 25, 2024
In the fast-paced realm of pharmaceuticals, where innovation can mean the difference between life and death, the integration of artificial intelligence (AI) is reshaping the landscape of drug discovery and development.
Digital Health Global
SEPTEMBER 27, 2023
Our mission is to accelerate the commercialization of breakthrough innovations like the AUTAC platform for health impact, and we welcome Automera and ALSP to Singapore’s growing life sciences translational community.” We invest and partner with innovators, entrepreneurs, and founders to launch and grow global companies in Singapore.
Healthcare IT News - Telehealth
JANUARY 20, 2022
That is the opinion of Ron Emerson, RN, global healthcare lead at Zoom, as he looks ahead at what he believes will be some developments in healthcare in 2022. You predict that decentralization will become a major theme for health and life science organizations. Please elaborate.
Healthcare IT Today
JANUARY 7, 2025
Chris McSpiritt, Head of Life Sciences at Domino Data Lab Next year will see AI-enhanced imaging technologies significantly improve diagnostic accuracy in radiology and pathology, empowering clinicians to make quicker and more reliable decisions at the point of care. Today, it’s largely restricted to genomics and oncology.
Lloyd Price
NOVEMBER 16, 2024
The new company aims to leverage its extensive data sets and technology to provide innovative solutions across various healthcare sectors, including life sciences, provider, imaging, health plan, employer, and government health and human services. These challenges include: High costs: Watson is expensive to develop and maintain.
Expert insights. Personalized for you.
92 
Let's personalize your content